Characteristics of the cohort of patients with COVID-19
| Characteristic | Complicated (%) (n=291) | Home (%) (n=5783) | |
| Outcome | Nursing home | 59 (20.3) | – |
| Hospitalisation | 181 (62.2) | – | |
| Deceased | 51 (17.5) | – | |
| Age group (years) | <40 | 17 (5.8) | 2186 (37.8) |
| 40–49 | 16 (5.5) | 985 (17.0) | |
| 50–59 | 34 (11.7) | 1204 (20.8) | |
| 60–69 | 43 (14.8) | 758 (13.1) | |
| 70–79 | 66 (22.7) | 436 (7.5) | |
| 80–89 | 79 (27.1) | 178 (3.1) | |
| 90+ | 36 (12.4) | 36 (0.6) | |
| Sex | Woman | 144 (49.5) | 3352 (58.0) |
| Man | 147 (50.5) | 2431 (42.0) | |
| Timing | Period before August | 197 (67.7) | 2123 (36.7) |
| Period starting in August | 94 (32.3) | 3660 (63.3) | |
| Province | South Holland | 92 (31.6) | 2102 (36.3) |
| North Brabant | 82 (28.2) | 2495 (43.1) | |
| North Holland | 67 (23) | 821 (14.2) | |
| Limburg | 33 (11.3) | 227 (3.9) | |
| Other | 17 (5.8) | 138 (2.4) | |
| Tested | Negative or not | 49 (16.8) | 1025 (17.7) |
| Positive | 242 (83.2) | 4758 (82.3) | |
| NDS | Middle | 85 (29.2) | 2241 (38.8) |
| Low | 150 (51.5) | 1900 (32.9) | |
| High | 56 (19.2) | 1642 (28.4) | |
| Obesity | BMI ≥30 kg/m2 | 50 (17.2) | 611 (10.6) |
| Comorbidity | Cancer | 84 (28.9) | 507 (8.8) |
| Cardiovascular disease | 188 (64.6) | 1405 (24.3) | |
| Diabetes | 64 (22.0) | 440 (7.6) | |
| Heart valve disease | 21 (7.2) | 87 (1.5) | |
| Immunosuppressants | 41 (14.1) | 421 (7.3) | |
| Kidney disease | 67 (23.0) | 280 (4.8) | |
| Liver disease | 7 (2.4) | 89 (1.5) | |
| Lung disease | 64 (22.0) | 864 (14.9) | |
| Neurological disease | 42 (14.8) | 187 (3.2) | |
| Indication | Influenza vaccination | 225 (77.3) | 2392 (42.3) |
| CCS | 0 | 60 (20.6) | 3250 (56.2) |
| 1 | 49 (16.8) | 1430 (24.7) | |
| 2 | 74 (25.4) | 655 (11.3) | |
| 3 | 65 (22.3) | 297 (5.1) | |
| 4 | 31 (10.7) | 113 (2.0) | |
| 5+ | 12 (4.1) | 38 (0.7) |
BMI, body mass index; CCS, chronic comorbidity score; NDS, neighbourhood deprivation score.